Search - tctmd.com

Displaying 1 - 20 of 101

Sort: Relevancy | Date

Presentation TCT 2025

TCT 59: Evolocumab in Patients with Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

Presenter: Jinying Zhou

October 28, 2025

Presentation TCT 2025

TCT 944: Accuracy of Artificial Intelligence Driven Prediction of Target Vessel Failure Post-PCI: A Systematic Review and Meta-Analysis

Presenter: Rahul Ravindra

October 27, 2025

Presentation TCT 2025

TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study

Presenter: Kunal Mahajan

October 27, 2025

Presentation TCT 2025

Clinical Case 2: Targeting Inflammation After PCI – Translating Evidence into Practice

Presenter: Davide Capodanno

October 26, 2025

Presentation TCT 2025

ACS Pharma Trials On The Horizon: Other Lipid Targets - Lpa and CETP Inhibitors

Presenter: Dharam J. Kumbhani

October 26, 2025

Presentation TCT 2025

From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis

Presenter: Linda D. Gillam

October 26, 2025

Presentation TCT 2025

Equity in PE Care: New Models for Timely, Targeted Intervention

Presenter: Andrew Sharp

October 25, 2025

Presentation TCT 2025

The PE Treatment Gap: What the Data Says About Who Gets What

Presenter: Kenneth Rosenfield

October 25, 2025

Presentation TCT 2025

ARS 11: Pulmonary Embolism Care Is Not Created Equal: Gaps, Variability, and Outcomes

Presenter: Wayne Batchelor

October 25, 2025

Presentation TCT 2025

From Data to Delivery: AI-Based Solutions to Democratize Structural Heart Care

Presenter: Sammy Elmariah

October 25, 2025

Presentation TCT 2025

Barriers to the Valve: Who’s Left Behind in Structural Heart Care?

Presenter: Wayne Batchelor

October 25, 2025

Presentation TCT 2025

ARS 10: From Indication to Intervention: Gaps in Structural Heart Treatment Delivery

Presenter: Ingrid Ellerbe

October 25, 2025

Presentation TCT 2025

Reimagining MI Treatment: AI-Driven STEMI Systems v2.0

Presenter: Ivan C. Rokos

October 25, 2025

Presentation TCT 2025

From Door-to-Balloon to Equity: Are We Closing the Gaps?

Presenter: Louis A. Cannon

October 25, 2025

Presentation TCT 2025

ARS 9: Acute MI Management: We Are Not All Treated Equally!

Presenter: Samuel Conaway

October 25, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Daily News

Eclampsia in Pregnancy Sharply Increases Risk of CVD in the Year After Delivery

Caitlin E. Cox

July 31, 2025

Advertisement

TCT 59: Evolocumab in Patients with Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

TCT 944: Accuracy of Artificial Intelligence Driven Prediction of Target Vessel Failure Post-PCI: A Systematic Review and Meta-Analysis

TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study

Clinical Case 2: Targeting Inflammation After PCI – Translating Evidence into Practice

ACS Pharma Trials On The Horizon: Other Lipid Targets - Lpa and CETP Inhibitors

From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis

Equity in PE Care: New Models for Timely, Targeted Intervention

The PE Treatment Gap: What the Data Says About Who Gets What

ARS 11: Pulmonary Embolism Care Is Not Created Equal: Gaps, Variability, and Outcomes

From Data to Delivery: AI-Based Solutions to Democratize Structural Heart Care

Barriers to the Valve: Who’s Left Behind in Structural Heart Care?

ARS 10: From Indication to Intervention: Gaps in Structural Heart Treatment Delivery

Reimagining MI Treatment: AI-Driven STEMI Systems v2.0

From Door-to-Balloon to Equity: Are We Closing the Gaps?

ARS 9: Acute MI Management: We Are Not All Treated Equally!

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Eclampsia in Pregnancy Sharply Increases Risk of CVD in the Year After Delivery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content